Bio-Path Holdings, Inc. (BPTH)
BPTH moved a median of 0.00% 30 minutes after news, and -1.47% by the close. How BPTH actually reacts to news — the realized, point-in-time move the market made, measured across 168 labeled events over the last three years with zero look-ahead.
BPTH’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 23% | 152 |
| 30-min | 0.00% | 43% | 154 |
| 60-min | -0.24% | 37% | 161 |
| to close | -1.47% | 36% | 167 |
| Middle 50% of BPTH reactions | -2.84% to +1.95% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 168 |
Half of all Bio-Path Holdings, Inc. news events land between -2.84% and +1.95% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when BPTH moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BPTH's baseline. Nothing else.
Recent BPTH events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 1-SA BIO-PATH HOLDINGS, INC. For: Aug 19 | SEC filing · Form 1-SA | SEC EDGAR | — | — | |
| Form 253G2 BIO-PATH HOLDINGS, INC. | SEC filing · Form 253G2 | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | — | -1.90% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: May 14 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| Form 15-12G BIO-PATH HOLDINGS, INC. | SEC filing · Form 15-12G | SEC EDGAR | +0.00% | +17.14% | |
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -19.77% | |
| Form NT 10-Q BIO-PATH HOLDINGS, INC. For: Mar 31 | SEC filing · Form NT | SEC EDGAR | — | +0.00% | |
| Form 1-K BIO-PATH HOLDINGS, INC. For: Dec 31 | SEC filing · Form 1-K | SEC EDGAR | — | -0.46% | |
| Form QUALIF BIO-PATH HOLDINGS, INC. | SEC filing · Form QUALIF | SEC EDGAR | -4.57% | -0.85% | |
| Form 1-A BIO-PATH HOLDINGS, INC. | SEC filing · Form 1-A | SEC EDGAR | — | +3.17% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Jan 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.87% | |
| Form 1-Z BIO-PATH HOLDINGS, INC. | SEC filing · Form 1-Z | SEC EDGAR | +0.00% | +5.08% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Jan 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -5.47% | |
| Form NT 10-Q BIO-PATH HOLDINGS, INC. For: Sep 30 | SEC filing · Form NT | SEC EDGAR | — | +0.00% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | — | +8.31% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Oct 22 | SEC filing · Form 8-K | SEC EDGAR | — | +1.66% | |
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +7.17% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Jun 20 | SEC filing · Form 8-K | SEC EDGAR | +19.73% | -11.50% | |
| Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum | Press release | GlobeNewswire | +0.00% | +1.93% | |
| Bio-Path Holdings Provides Clinical and Operational Update | Press release | GlobeNewswire | -5.88% | -3.53% | |
| Form 253G3 BIO-PATH HOLDINGS, INC. | SEC filing · Form 253G3 | SEC EDGAR | -5.88% | -3.53% | |
| Form QUALIF BIO-PATH HOLDINGS, INC. | SEC filing · Form QUALIF | SEC EDGAR | +0.00% | +0.00% | |
| Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025 | Press release | GlobeNewswire | +0.00% | +5.88% | |
| Form 1-A/A BIO-PATH HOLDINGS, INC. | SEC filing · Form 1-A | SEC EDGAR | +0.00% | +5.16% | |
| Form 10-Q BIO-PATH HOLDINGS, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -7.69% | -5.13% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: May 01 | SEC filing · Form 8-K | SEC EDGAR | +11.11% | +11.04% | |
| Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients | Press release | GlobeNewswire | -9.87% | +0.00% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Apr 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 1-A BIO-PATH HOLDINGS, INC. | SEC filing · Form 1-A | SEC EDGAR | +0.00% | +2.24% | |
| Form RW BIO-PATH HOLDINGS, INC. | SEC filing · Form RW | SEC EDGAR | +0.00% | -7.04% | |
| Bio-Path Holdings Reports Full Year 2024 Financial Results | Press release | GlobeNewswire | +0.00% | -11.31% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Mar 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -11.31% | |
| Form 10-K BIO-PATH HOLDINGS, INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -11.31% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Mar 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +15.98% | |
| Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients | Press release | GlobeNewswire | +0.00% | -8.65% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Mar 06 | SEC filing · Form 8-K | SEC EDGAR | -8.28% | -6.67% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Feb 14 | SEC filing · Form 8-K | SEC EDGAR | -17.68% | -42.39% | |
| Bio-Path Holdings Expands Global Patent Portfolio | Press release | GlobeNewswire | -1.16% | +0.51% | |
| Bio-Path Holdings Provides Key Clinical Updates | Press release | GlobeNewswire | -5.55% | -5.97% | |
| Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid Leukemia | Press release | GlobeNewswire | -5.55% | -5.97% | |
| Form S-1/A BIO-PATH HOLDINGS, INC. | SEC filing · Form S-1 | SEC EDGAR | -0.66% | -6.49% | |
| Form S-1 BIO-PATH HOLDINGS, INC. | SEC filing · Form S-1 | SEC EDGAR | +3.01% | +1.48% | |
| Bio-Path Holdings Provides 2025 Clinical and Operational Update | Press release | GlobeNewswire | +4.18% | -3.16% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Jan 10 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.67% | |
| Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients Enhances Insulin Sensitivity | Press release | GlobeNewswire | +4.63% | -54.01% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Dec 19 | SEC filing · Form 8-K | SEC EDGAR | -11.42% | -9.35% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Dec 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.09% | |
| Form 8-K BIO-PATH HOLDINGS, INC. For: Dec 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -9.79% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BPTH section they belong to.
Where else BPTH is measured.
BPTH earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ESSILOR LXTTCA UNSP/ADR (ESLOY) | 169 | -0.01% | 45% |
| BODY AND MIND INC (BMMJ) | 168 | 0.00% | 31% |
| Iterum Therapeutics plc - Ordinary Share (ITRM) | 168 | 0.00% | 49% |
| BIOSTAR PHARMS INC (BSPM) | 167 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Bio-Path Holdings, Inc.'s median reaction calculated?
Every labeled BPTH news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 168 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 43% of BPTH's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BPTH's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.